STOCK TITAN

Jupiter Neurosciences (JUNS) CAO converts RSAs and RSUs into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. Chief Administrative Officer Alexander Gustaf Erik Rosen exercised equity awards into common stock. On 2 June 2025, he converted 96,608 Restricted Stock Awards and 164,554 Restricted Stock Units, each on a one-for-one basis into common shares at a $0.0000 exercise price, following the expiration of the IPO lock-up period.

Positive

  • None.

Negative

  • None.
Insider Rosen Alexander Gustaf Erik
Role Chief Administrative Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 164,554 $0.00 --
Exercise Restricted Stock Award 96,608 $0.00 --
Exercise Common Stock 164,553 -- --
Exercise Common Stock 96,608 -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Restricted Stock Award — 0 shares (Direct); Common Stock — 520,803 shares (Direct)
Footnotes (1)
  1. These securities convert into common stock on a one-for-one basis. These awards vested on the expiration of the lock-up period for the Issuer's initial public offering.
Restricted Stock Awards exercised 96,608 shares Restricted Stock Awards converted into common stock on June 2, 2025
Restricted Stock Units exercised 164,554 units Restricted Stock Units converted into common stock on June 2, 2025
Total derivative exercises 261,162 shares ExerciseShares reported in transaction summary for code M transactions
RSA exercise price $0.0000 per share Exercise or conversion price for Restricted Stock Award entry
RSA expiration date July 21, 2032 Expiration date for the Restricted Stock Award derivative security
RSU expiration date December 17, 2033 Expiration date for the Restricted Stock Units derivative security
Restricted Stock Units financial
"The security title includes Restricted Stock Units as a derivative award."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Restricted Stock Award financial
"One derivative entry lists the security title as Restricted Stock Award."
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
lock-up period financial
"Awards vested on the expiration of the lock-up period for the IPO."
A lock-up period is a fixed time after a stock offering during which company insiders and early investors are legally barred from selling their shares. It matters because when that restriction expires a large block of previously locked-up shares can enter the market at once, potentially lowering the stock price or spiking trading volume—like opening a floodgate—so investors monitor these dates to anticipate price moves and manage risk.
initial public offering financial
"The awards vested on expiration of the lock-up period for the Issuer's initial public offering."
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did JUNS executive Alexander Rosen report in this Form 4?

Alexander Rosen reported exercising equity awards into common stock, converting 96,608 Restricted Stock Awards and 164,554 Restricted Stock Units on June 2, 2025, each on a one-for-one basis into Jupiter Neurosciences common shares.

Did JUNS Chief Administrative Officer sell any shares in this filing?

No. The Form 4 shows no open-market sales. All four transactions are coded "M," meaning exercises or conversions of derivative securities into common stock, with no reported sales or tax-withholding dispositions.

How many JUNS shares were acquired through award exercises on June 2, 2025?

The filing shows derivative exercises totaling 261,162 shares, including 96,608 shares from Restricted Stock Awards and 164,554 from Restricted Stock Units, all converting into common stock on a one-for-one basis.

What types of equity awards did JUNS use for Alexander Rosen?

Alexander Rosen held Restricted Stock Awards and Restricted Stock Units. On June 2, 2025 these awards vested and converted into Jupiter Neurosciences common stock, with the awards originally tied to the company’s initial public offering lock-up period.

Why did Alexander Rosen’s JUNS awards vest on June 2, 2025?

A footnote states the awards vested upon expiration of the lock-up period for Jupiter Neurosciences’ initial public offering, triggering the conversion of the Restricted Stock Awards and Restricted Stock Units into common shares on that date.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rosen Alexander Gustaf Erik

(Last)(First)(Middle)
C/O JUPITER NEUROSCIENCES, INC.
11621 KEW GARDENS AVE, SUITE 210

(Street)
PALM BEACH GARDENS FLORIDA 33410

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Administrative Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2025M164,553A(1)520,803D
Common Stock06/02/2025M96,608A(1)617,411D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)06/02/2025M164,554 (2)12/17/2033Common Stock164,553$0.000D
Restricted Stock Award(1)06/02/2025M96,608 (2)07/21/2032Common Stock96,608$0.000D
Explanation of Responses:
1. These securities convert into common stock on a one-for-one basis.
2. These awards vested on the expiration of the lock-up period for the Issuer's initial public offering.
/s/ Alexander Rosen07/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)